Since the effect on MAdCAM-1 was more prominent than on ICAM-1, and as blocking MAdCAM-1 was previously shown to attenuate IBD (Vermeire et al., 2017), we focused on MAdCAM-1. This evidence concerns the gene ICAM1 and inflammatory bowel disease.